---
title: Trabid patient mutations impede the axonal trafficking of adenomatous polyposis
  coli to disrupt neurite growth
date: '2023-12-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38099646/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231215170616&v=2.18.0
source: heidelberg[Affiliation]
description: ZRANB1 (human Trabid) missense mutations have been identified in children
  diagnosed with a range of congenital disorders including reduced brain size, but
  how Trabid regulates neurodevelopment is not understood. We have characterized these
  patient mutations in cells and mice to identify a key role for Trabid in the regulation
  of neurite growth. One of the patient mutations flanked the catalytic cysteine of
  Trabid and its deubiquitylating (DUB) activity was abrogated. The second variant
  ...
disable_comments: true
---
ZRANB1 (human Trabid) missense mutations have been identified in children diagnosed with a range of congenital disorders including reduced brain size, but how Trabid regulates neurodevelopment is not understood. We have characterized these patient mutations in cells and mice to identify a key role for Trabid in the regulation of neurite growth. One of the patient mutations flanked the catalytic cysteine of Trabid and its deubiquitylating (DUB) activity was abrogated. The second variant ...